These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1635922)

  • 1. Studies on dressing for dental surgery use. Part 2. Influence of Kunitz' protease inhibitor on properties of dental gelatinous dressings.
    Dybek K; Kubis A; Małolepsza-Jarmołowska K
    Pharmazie; 1992 Feb; 47(2):132-3. PubMed ID: 1635922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on dressings for dental surgery use. Part 1: Effect of plasticizers on gelatin gel etching rate.
    Kubis A; Dybek K
    Pharmazie; 1991 Mar; 46(3):207-8. PubMed ID: 1881944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on dressings for mucosa of oral cavity. Part 1: Influence of hydrophilizing substances on xerogel properties of dressings comprising Kunitz protease inhibitor.
    Kubis A; Małecka K
    Pharmazie; 1988 Jul; 43(7):486-8. PubMed ID: 3222280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on dressings for mucosa of the oral cavity. Part 4: Influence of technology used in the preparation of dental xerogel dressings in the presence of acetone on their properties.
    Malecka K; Kubis AA
    Pharmazie; 1998 Jun; 53(6):396-8. PubMed ID: 9675769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on dressings for dental surgery use. Part 3: Effect of gamma-radiation and of formaldehyde on properties of gelatinous dental dressings.
    Dybek K; Kubis A; Rosiak J
    Pharmazie; 1992 Apr; 47(4):273-4. PubMed ID: 1518884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on dressings for treatment of mucous membranes of oral cavity. Part 2: Influence of hydrophilizing substances on properties of hydrogel dressings comprising Kunitz protease inhibitor.
    Małecka K; Kubis A
    Pharmazie; 1988 Oct; 43(10):694-6. PubMed ID: 3212015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on dressings for mucosal oral cavity. Part 6: Influence of a solvent and 1,2-propylene glycol on the pharmaceutic properties of dental xerogel dressings.
    Malecka K; Kubis AA
    Pharmazie; 2001 Aug; 56(8):669-70. PubMed ID: 11534352
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on dressings for oral cavity mucosa. Part 5: Properties of xerogel stomatological dressings with one-side antiadhesive coating.
    Malecka K; Kubis AA
    Pharmazie; 2001 Jan; 56(1):64-5. PubMed ID: 11210673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on dressings for mucosa of the oral cavity. Part 3: Effect of preparation technology on the physical and chemical properties of stomatological xerogel dressings.
    Małecka K; Kubis A
    Pharmazie; 1996 Apr; 51(4):240-1. PubMed ID: 8628740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kunitz-type soybean trypsin inhibitor revisited: refined structure of its complex with porcine trypsin reveals an insight into the interaction between a homologous inhibitor from Erythrina caffra and tissue-type plasminogen activator.
    Song HK; Suh SW
    J Mol Biol; 1998 Jan; 275(2):347-63. PubMed ID: 9466914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between duodenase, a proteinase with dual specificity, and soybean inhibitors of Bowman-Birk and Kunitz type.
    Gladysheva IP; Zamolodchikova TS; Sokolova EA; Larionova NI
    Biochemistry (Mosc); 1999 Nov; 64(11):1244-9. PubMed ID: 10611528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thermodynamic and kinetic study of thermal denaturation of Kunitz soybean trypsin inhibitor by differential scanning microcalorimetry].
    Varfolomeeva EP; Burova TV; Grinberg VIa; Tolstoguzov VB
    Mol Biol (Mosk); 1989; 23(5):1263-72. PubMed ID: 2608035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human.
    Itoh H; Kataoka H; Hamasuna R; Kitamura N; Koono M
    Biochem Biophys Res Commun; 1999 Feb; 255(3):740-8. PubMed ID: 10049781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of lipopolysaccharide-induced cytokine production of gingival fibroblasts by a soybean, Kunitz trypsin inhibitor.
    Kobayashi H; Yoshida R; Kanada Y; Fukuda Y; Yagyu T; Inagaki K; Kondo T; Kurita N; Suzuki M; Kanayama N; Terao T
    J Periodontal Res; 2005 Dec; 40(6):461-8. PubMed ID: 16302924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peltophorum dubium and soybean Kunitz-type trypsin inhibitors induce human Jurkat cell apoptosis.
    Troncoso MF; Biron VA; Longhi SA; Retegui LA; Wolfenstein-Todel C
    Int Immunopharmacol; 2007 May; 7(5):625-36. PubMed ID: 17386410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator.
    Kataoka H; Itoh H; Nuki Y; Hamasuna R; Naganuma S; Kitamura N; Shimomura T
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1096-100. PubMed ID: 11798188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Erythrina protease inhibitor: interactions with tissue plasminogen activator.
    Heussen-Schemmer C; Merrifield EH; Dowdle EB
    Thromb Haemost; 1991 Aug; 66(2):226-31. PubMed ID: 1771616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function relationship for Kunitz and Kazal type trypsin inhibitors.
    Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Antonini E
    Farmaco Sci; 1983 Dec; 38(12):978-97. PubMed ID: 6365586
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mode of action and pharmacokinetics of a polyvalent protease inhibitor (Kunitz' inhibitor)].
    Hureau J; Kher A; Vairel EG
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:15-8. PubMed ID: 4587010
    [No Abstract]   [Full Text] [Related]  

  • 20. Swelling of hydrocolloid dressings.
    Lanel B; Barthès-Biesel D; Regnier C; Chauvé T
    Biorheology; 1997; 34(2):139-53. PubMed ID: 9373396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.